Sinopharm Group Co Ltd represents the values of integrity, innovation, and excellence. The company is guided by a corporate philosophy that prioritizes customer-centricity and social responsibility. With a focus on healthcare, Sinopharm Group Co Ltd strives to provide high-quality medical products and services to people worldwide. Through continuous research and development, they aim to improve healthcare access and enhance well-being. By upholding its values and corporate philosophy, Sinopharm Group Co Ltd actively contributes to the advancement of the global healthcare industry, making a positive impact on people's lives.

Sinopharm Group Co Ltd is primarily present in China.

Sinopharm Group Co Ltd has achieved several significant milestones throughout its history. One notable accomplishment is the company's successful listing on the Hong Kong stock exchange in 2009, followed by its inclusion in the Hang Seng Index in 2011. Sinopharm has also made significant advancements in the healthcare industry, expanding its portfolio through acquisitions and strategic collaborations. Notably, the company established Sinopharm Holding Guoda Drugstore, an integrated pharmaceutical retailer. In addition, Sinopharm is at the forefront of medical research and development, collaborating with international pharmaceutical companies and contributing to the innovation of new drugs. Sinopharm Group Co Ltd continues to strive for excellence and cement its position as a leading global healthcare company.

Sinopharm Group Co Ltd, a renowned pharmaceutical and healthcare company, has a rich history and stellar background. Established in 2003, Sinopharm has emerged as a leading player in the healthcare industry. It operates in various segments, including distribution, retail, manufacturing, research, and more. With headquarters in Beijing, China, Sinopharm has focused on expanding its operations globally, establishing a presence across 150 countries. The company strives to improve healthcare accessibility and quality by offering a wide range of products and services, including pharmaceuticals, medical devices, and healthcare solutions. Sinopharm Group Co Ltd's commitment to innovation, quality, and professionalism has earned it a strong reputation in the global market.

The main competitors of Sinopharm Group Co Ltd in the market are Shanghai Fosun Pharmaceutical Group Co Ltd, China Resources Pharmaceutical Group Ltd, and CSPC Pharmaceutical Group Ltd.

Sinopharm Group Co Ltd is primarily active in the healthcare industry.

The business model of Sinopharm Group Co Ltd focuses on providing pharmaceutical and healthcare products and services. Sinopharm Group operates through various segments, including Distribution, Retail Pharmacy, Pharmaceutical Manufacturing, and others. As China's largest pharmaceutical distribution and retail company, Sinopharm Group plays a crucial role in the healthcare industry. The company offers a wide range of products, including prescription drugs, over-the-counter medicines, medical devices, and healthcare services. Sinopharm Group aims to enhance the accessibility and affordability of quality healthcare by ensuring the efficient supply chain and expanding its reach across different regions in China.

مُعامل القيمة السوقية إلى الأرباح لـ Sinopharm Group Co هو ١١٫٠٢.

مُعامِل القيمة إلى المبيعات Sinopharm Group Co هو ٠٫٠٧.

نقاط جودة AlleAktien لـ Sinopharm Group Co هي 9/10.

المتوقعة Sinopharm Group Co الإيرادات هي ٦٥٩٫١٣ مليارات CNY.

صافي الربح المتوقعة Sinopharm Group Co هو ٤٫٣٤ مليارات CNY.

Sinopharm Group Co Ltd is a leading Chinese company specializing in the manufacturing and marketing of pharmaceutical products, medical devices, vaccines, health products, and services. The company covers a wide range of business areas, including the production of medicines, vaccines, medical devices, and medical services. It focuses on customizing its offerings to meet the needs of end customers, establishing itself as a strong player in the global market. The company's main emphasis is on the production and marketing of pharmaceutical products, including a wide range of medicines and medical devices such as eye drops, cough and cold medicines, vitamins and minerals, painkillers, antibiotics, and cancer therapeutics. Sinopharm Group Co Ltd is also a leading provider of vaccines, producing and distributing a broad range of vaccines including those for Hepatitis B, rabies, measles, mumps, and rubella. Additionally, the company offers health products like dietary supplements, diagnostic devices, and medical accessories. It also develops and manufactures medical devices such as urinary catheters, implants, and stents. In addition to these areas, Sinopharm Group Co Ltd is also involved in other segments of the healthcare industry such as hospital management and medical services. It operates a chain of hospitals and pharmacies in China, providing medical services such as consultations, diagnoses, prevention, and rehabilitation. The company's business model is focused on offering products and services tailored to the needs and demands of customers. It invests in research and development to create innovative and cost-effective products and solutions.

يوزع Sinopharm Group Co أرباحًا قدرها ٠٫٨٧ CNY من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Sinopharm Group Co في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـSinopharm Group Co هو CNE100000FN7.

رمز WKN لـ Sinopharm Group Co هو A0N99U.

الرمز المُختصر لـ Sinopharm Group Co هو 1099.HK.

خلال آخر 12 شهراً، دفعت Sinopharm Group Co توزيعات أرباح بقيمة ٠٫٩٠ CNY . وهذا يعادل عائد توزيعات أرباح يقارب ٥٫٨٨ %. ومن المتوقع أن تدفع Sinopharm Group Co خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٠٫٩٨ CNY.

نسبة توزيعات الأرباح الحالية لـ Sinopharm Group Co هي ٥٫٨٨ %.

Sinopharm Group Co يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر يوليو, يوليو, يوليو, يوليو.

Sinopharm Group Co دفعت توزيعات الأرباح كل عام خلال الـ19 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٠٫٩٨ CNY. وهذا يعادل عائد توزيعات أرباح قدره ٦٫٣٨ %.

Sinopharm Group Co يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫٩٥٦ CNY من Sinopharm Group Co المُعلن عنها في ١٣‏/٨‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ١٧‏/٦‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ١٣‏/٨‏/٢٠٢٤.

في العام 2023، وزعت Sinopharm Group Co ٠٫٨٧٢ CNY كأرباح أسهم.

يتم توزيع أرباح Sinopharm Group Co بالعملة CNY.